Geriatric assessment to predict toxicity in elderly patients with unresectable locally advanced non-small-cell lung cancer treated with concurrent chemoradiotherapy.

被引：1

作者：

Nadal, Ernest

Carlos Ruffinelli, Jose

Palmero, Ramon

Navarro, Arturo

Plana, Maria

Mesia Barroso, Carlos

Dolores Arnaiz, Maria

Brao, Isabel

Arellano, Monica

Padrones, Susana

Borras, Josep Maria

Cardenal, Felipe

Saldana, Juana

Antonio Rebollo, Maite

机构：

[1] Catalan Inst Oncol, Dept Med Oncol, Lhospitalet De Llobregat, Barcelona, Spain

[2] Catalan Inst Oncol, Dept Radiat Oncol, Lhospitalet De Llobregat, Barcelona, Spain

[3] Inst Catala Oncol, Barcelona, Spain

[4] Bellvitge Univ Hosp, Dept Resp Med, Lhospitalet De Llobregat, Barcelona, Spain

[5] IDIBELL, Dept Hlth, Catalonian Canc Strategy, Lhospitalet De Llobregat, Barcelona, Spain

[6] Catalan Inst Oncol, Hospitalet Barcelona, Oncogeriatr Unit, Lhospitalet De Llobregat, Barcelona, Spain

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期

关键词：

D O I：

10.1200/JCO.2018.36.15_suppl.8557

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8557

引用

页数：1

共 50 条

[1] EFFICACY OF CONCURRENT CHEMORADIOTHERAPY IN LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER
Almodovar, M.
Ramos, H.
Mota, P.
Martins, V.
Pereira, P.
LUNG CANCER, 2011, 71 : S42 - S43
[2] Elderly Patients with Locally Advanced and Unresectable Non-Small-Cell Lung Cancer May Benefit from Sequential Chemoradiotherapy
Zaborowska-Szmit, Magdalena
Olszyna-Serementa, Marta
Kowalski, Dariusz M.
Szmit, Sebastian
Krzakowski, Maciej
CANCERS, 2021, 13 (18)
[3] Concurrent radiochemotherapy with ifosfamide in locally advanced unresectable non-small-cell lung cancer
Manegold, C
Latz, D
ONKOLOGIE, 1998, 21 : 15 - 18
[4] Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer
Katayama, H
Ueoka, H
Kiura, K
Tabata, M
Kozuki, T
Tanimoto, M
Fujiwara, T
Tanaka, N
Date, H
Aoe, M
Shimizu, N
Takemoto, M
Hiraki, Y
BRITISH JOURNAL OF CANCER, 2004, 90 (05) : 979 - 984
[5] Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer
H Katayama
H Ueoka
K Kiura
M Tabata
T Kozuki
M Tanimoto
T Fujiwara
N Tanaka
H Date
M Aoe
N Shimizu
M Takemoto
Y Hiraki
British Journal of Cancer, 2004, 90 : 979 - 984
[6] Evaluation of Chemoradiotherapy Toxicity in Geriatric Patients Diagnosed with Locally Advanced Non-Small Cell Lung Cancer
Kizilgoz, Derya
Kabalak, Pinar Akin
Kavurgaci, Suna
Yilmaz, Ulku
INTERNATIONAL JOURNAL OF GERONTOLOGY, 2023, 17 (04) : 254 - 257
[7] NIMOTUZUMAB IN COMBINATION WITH CONCURRENT CHEMORADIOTHERAPY (CRT) IN PATIENTS WITH LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)
Satouchi, M.
ANNALS OF ONCOLOGY, 2012, 23 : 57 - 57
[8] A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer
Giorgio, Carmelo G.
Pappalardo, Alessandro
Russo, Antonio
Santini, Daniele
Di Rosa, Carlo
Di Salvo, Carmela
Castorina, Sergio
Marletta, Franco
Bellissima, Giuseppe
Palermo, Nuccio
Scuderi, Concetto
Bordonaro, Roberto
ANTI-CANCER DRUGS, 2007, 18 (06) : 713 - 719
[9] Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients With Unresectable Stage III Non-Small-Cell Lung Cancer (PACIFIC)
Socinski, Mark A.
Ozguroglu, Mustafa
Villegas, Augusto
Daniel, Davey
Vicente, David
Murakami, Shuji
Hui, Rina
Gray, Jhanelle E.
Park, Keunchil
Vincent, Mark
Mann, Helen
Newton, Michael
Dennis, Phillip A.
Antonia, Scott J.
CLINICAL LUNG CANCER, 2021, 22 (06) : 549 - 561
[10] Mutagen sensitivity (MS) may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer (NSCLC) treated by chemoradiotherapy.
Komaki, R
Spitz, MR
Wu, X
Chang, JY
Allen, PK
Lika, M
Fossella, FV
Stevens, CW
Liao, Z
Cox, JD
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 674S - 674S

← 1 2 3 4 5 →